Thursday, August 30, 2018

India ATM Cash Management Market Forecast to 2023 – Ken Research


The report titled India ATM Cash Management Market Forecast to 2023 - by ATM Replenishment, Cash in Transit, Cash Pickup and Delivery and Vaulting Services, Bullion Management, and Cash Processing provides a comprehensive analysis of India ATM Cash Management Services market introduction and genesis, market size by revenue and working model. The report provides competitive landscape of major players in India Cash Management Services market such as CMS Info System, SIS Prosegur, Brink’s Arya, Writer Safeguard, Securevalue, Logicash and Radiant Cash. The report also covers future projections. The report is useful for ATM Managed service providers, Cash management companies, ATM Manufacturers, White Label ATM Management companies, Banks, Reserve Bank of India (RBI), ATM Switch companies, Cash Reconciliation companies, Digital payments merchants and other stake holders to align their market centric strategies according to ongoing and expected trends in the future.

Market Overview:
Until 2000s, banks were offering the ATM services only to their branch customers. With the aim to progress towards a cashless economy, the banks enabled the concept of branchless banking and hence allowed their account holders as well as non-account holders (belonging to other banks) to withdraw cash from their ATMs. Post 2010, banks started to outsource management of ATM to specialized ATM managed services companies. This initiative has helped banks to enhance their penetration in rural and urban areas, on the onset of rising competition among public, private and foreign banks and the quest of RBI to strengthen the financial sector.
Currently ATM Cash management services market is at a developing stage. The Cash Management Services Market is moderately fragmented among top 6-7 players which constituted majority of the revenue share though there are number of smaller players existing in the market.

Market Size: Cash Management is the process of collecting, managing and investing cash in an ATM which are outsourced by banks to MSPs. The current cash management cycle involves cash pick up from bank, cash movement from the bank to the ATMs’ locations, grading, counting, monitoring ATMs for assessing the level of cash in an ATM, and replenishing cash in the machine accordingly. On the other hand, Cash Management companies has undergone in a partnership to form Cash Logistic Association (CLA) during the year 2013, to structure down the growth of India’s ATM infrastructure. India cash management services market increased positively at a double digit CAGR during the period FY’2013 - FY’ 2018, majorly due to increase in services offered by the cash management companies including cash vault services, bullion management, cash processing and others. High number of cash transaction in ATMs directly contributed to the increasing growth of Cash Management Services in India.

Cash Management market has observed a decline in growth rate during FY’ 2016 to FY’2017 due to effect of demonetization on the financial sector which negatively affected the profitability of cash management companies as majority of the ATMs remained out of cash during the period of demonetization. However, in FY’ 18 cash in circulation is back and is currently at an all-time high.

Market Segmentation
By Services: Cash management service companies (CMC) generates highest share of their revenue through ATM replenishment service. On the other hand, CIT contributed third largest share in generating revenue for the cash management companies in the FY’ 2017. However, CIT service turned out to be the second major contributor in terms of revenue share during FY’2018 majorly due to increase in license of new bank branches during the above period. CPD contributed the third largest share in terms of revenue for the cash management companies due to increase in number of retail touch points.

Competition Scenario: The market of Cash Management services in India is moderately concentrated. There are few players which have global presence while some of the players are in plans to expand towards PAN India level. There is a rising trend of increasing the ATM reach to the population in rural, semi-urban areas and thus such companies look forward to get contracts to achieve the same. With expected increase in the FDI in the Cash Management market, it is expected that with the entry of new foreign entrants, the market will become more fragmented in the near future. CMS Infosystem, Writer Safeguard, SIS Prosegur, Securevalue, Radiant Cash, Brink’s Arya, Logicash are some of the major players which constitute majority of the overall Cash Management Market. Out of these players, CMS Infosystem continues to be the market leader for past 4 years.

Future Outlook and Projections:
By Revenue: It is anticipated that India cash management services market will generate revenue at a positive single digit CAGR during the period FY’ 2018 - FY’ 2023. This is majorly due to increasing deployment of ATMs in rural areas under the financial inclusion scheme imposed by Indian government. Schemes such as Pradhan Mantri Jan Dhan Yojana (PMJDY) has further increased the demand of cash at ATMs as number of active ATM card holders have increased rapidly, which will directly increase the demand of cash management companies. On the other hand, it is anticipated that market of cash management services will increase gradually with the high number of cash transaction in ATMs. Though there are government reforms to move the economy towards cashless, Cash has and is expected to continue to remain King in terms of payments and transactions.

Target Audience:-
ATM Security Services/ Solutions Providers
ATM Cash Management Companies
Banks and NBFCs
ATM Managed Services Providers
ATM Manufacturers
White Label ATM Management companies
Reserve Bank of India (RBI)
ATM Switch companies
Cash Reconciliation companies
Digital Payments Merchants

Products Covered:-
ATM Replenishment
Cash-in-Transit (CIT)
CPD (Cash Pickup and Delivery) /RCM (Retail Cash Management)
Vaulting Services, Bullion Management, and Cash Processing

Companies Covered:-
CMS Infosystem, Writer Safeguard, SIS Prosegur, Securevalue, Radiant Cash, Brink’s Arya, Logicash

Key Topics Covered in the Report:-
India Cash Management Services Market Size (FY’2013-FY’2018)
India Cash Management Services Market Overview
India ATM Cash Management Services Market Segmentation By Services (ATM Replenishment, CIT, CPD And Others)
India ATM Managed Services market Ecosystem And Value Chain Analysis
Complete Competition Analysis Including Strength And Weakness Of The Major Companies
Competitive Landscape Of Major Players In India ATM Cash Management Services Market
Future Outlook And Projections Of India ATM Cash Management Services Market (FY’2023E)

For more information about the publication, refer to below link:-

Related Reports:-


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Global Construction Market Outlook to 2022: Ken Research

The Construction Intelligence Center (CIC) expects the pace of expansion in the Global Construction Industry to average 3.6% a year over the forecast period (2018-2022)-down slightly compared with 3.7% in the March 2018 forecast update. In real value terms (measured at constant 2017 prices and USD exchange rates), global construction output is forecast to rise to USD 12.7 trillion in 2022, up from USD 10.6 trillion in 2017.

The global economy will continue to post healthy rates of growth in 2018-2019, and investor confidence will remain buoyant. The expected tightening in monetary policy in major markets in 2018 will start to push up the cost of borrowing, but with interest rates generally at or near historic lows, this process is not expected to have a major impact on construction activity during the early part of the forecast period.

Construction output growth will accelerate marginally to 3.7% in 2019, before easing back in the latter part of the forecast period, reflecting trends in some of the largest markets, notably China and the US.

The acceleration in growth in global construction output in 2018-2019 is being driven primarily by the pickup in advanced economies, with combined growth in these markets rising to 2.7%, compared to 2.0% in 2017.

Although growth in emerging markets will remain in excess of that in advanced economies over the forecast period, there will be a steady slowdown in growth in construction spending in emerging markets-primarily reflecting trends in China, which has the largest construction market in the world. In 2018-2022, construction output growth in emerging markets will average 4.3% a year, down from 4.9% in 2013-2017.

The Asia-Pacific region will continue to account for the largest share of the global construction industry, given that it includes the large markets of China, Japan and India. The pace of growth will slow, however, given the projected slowdown in China's construction industry.

The emerging markets of South-East Asia will invest heavily in new infrastructure projects, supported by private investment. Meanwhile, construction growth in India will gather pace following a poor performance in 2017.

Construction activity is gathering momentum across Western Europe. The region's output will expand by 2.4% a year on average in 2018-2022, improving on the sluggish growth of 1.1% in 2013-2017.
An overview of the outlook for the global construction industry to 2022 Analysis of the outlook for the construction industry in major global regions: North America, Latin America, Western Europe, Eastern Europe, South and South-East Asia, North-East Asia, Australasia, the Middle East and North Africa, and Sub-Saharan Africa A comprehensive benchmarking of 83 leading construction markets according to construction market value and growth Analysis of the latest data on construction output trends in key markets.

To know more, click on the link below:

Related Reports:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

What Customers In Taiwanese Market Want From Payment Market : Ken Research


Ken Research’s Payments in Taiwan 2018: What consumers want gives a detailed insight about the consumers preferences and the major card payment option and the usage. The report identifies the competitors over the past five years and studies the strategies and market trends. The report also gives customer’s attitudes towards payment options and the change of trends over the past five years. The top market players in the payment industry of Taiwan are Chunghwa Post, Hua Nan Commercial Bank, Taiwan Cooperative Bank, First Commercial Bank, Cathay United Bank, Chinatrust Commercial Bank, E.SUN Bank, Taishin International Bank, Citibank, Visa, Mastercard, Smartpay, JCB, American Express.
Taiwan is a South East Asian state in Republic of China. In the 1960s, Taiwan faced rapid economic growth and industrial development creating a very stable economy. Between 1980s and 1990s, the country changed from a single-party dictatorship to a multi-party democracy. One of the Taiwan’s traditional habits of the locals is the culture of saving and can be seen even today. Studies show almost one-fourth of every money earned being saved in Taiwan. The country’s smartphone penetration is one of the highest in the whole world.  Global payments revenue has been increasing in multi-fold despite many disruptions in the market. As customers have become more and more comfortable with swiping cards and paying through mobile phones, the digitalisation of transaction industry is also expected to give way to its infrastructural development. In Taiwan, various digital players have entered into the market and increased customer awareness has driven the market for the payment industry.
While the whole world moved towards making payments online, Taiwan market still continues to prefer using cash. The reasons include sceptic business owners and other existing payment options satisfying the consumers there. However, the shift happened in 2015, where the government liberalised the electronic payments platform. As a result of this, various players like Apple Pay, Google Pay, WeChat Pay, Samsung Pay and Line Pay launched their services in the market. After the government passed the Act Governing Electronic Payment, the consumers making electronic payments almost doubled in two years of time. However, the lack of any unified standard in the mobile-payment sector, with credit cards, NFC contactless payments and QR code scanning all in use by various operators, there is uncertainty among consumers. The e-commerce market of Taiwan is one of the fastest growing in South-east Asia and will help grow the payments market.
To know more, click on the link below:
Related Reports:-
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-9015378249


Wednesday, August 29, 2018

Landscape of the Global Clinical Trials for Pheochromocytoma Market Outlook: Ken Research

A pheochromocytoma is usually a noncancerous tumor which is very much rare and develops in and adrenal gland. Adrenal gland make hormones that control metabolism, blood pressure, and other functions. It occurs most often during young-adult to mid-adult life. Moreover, few pheochromocytoma tumors spread to other organs which can be dangerous and should be treated right away. A pheochromocytoma also liberate hormones which are made by adrenal gland and does so at much excessive levels than normal. High blood pressure may be the only symptom of pheochromocytoma but in many cases of different people it has been observed that there are few more symptoms such as dizziness when standing, severe headache, unusual sweating, stomachache, side or pack pain and others. With the time if the treatment of pheochromocytoma will be not done then it will result in severe or life-threatening damage to other body systems, majorly the cardiovascular system. Additionally, there are some less common symptoms which are also observed in the patient of pheochromocytoma which includes anxiety or sense of doom, constipation, weight loss and others.

According to the report analysis, ‘Pheochromocytoma Global Clinical Trials Review, H1, 2018’ suggests that some of the major companies and healthcare organizations are currently working for the better treatment of pheochromocytoma includes Progenics Pharmaceuticals Inc, Pfizer Inc, Ono Pharmaceuticals Co. Ltd., Insights Pharmaceuticals Inc., Exelixis Inc, Endo International Plc., Eisai Co Ltd., Bristol-Myers Squibb Co., AstraZeneca pla., AbbVie Inc., Daiichi Sankyo Company , Ltd., Bayer AG, GE Healthcare, The University of Texas M.D. Anderson Cancer Center, Vanderbilt Medical center Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of cancer, Mayo Clinic, Duke University, University of Pennsylvania, Abbott Laboratries, National Cancer Center, and others across the globe. Additionally, with more development and research in this disease of pheochromocytoma many organizations are working very industriously for helping the patients for getting rid of this disease.

Pheochromocytoma can cause unwillingness arterial hypertension which will be well controlled with standard blood pressure medications. Although the problem of blood pressure all the time is a primary sign of a pheochromocytoma. Whereas, researchers don’t know what the causes of pheochromocytoma are but it is observed that about 30%, however, seem to run in families. The tumors which are more common in people with inherited condition includes multiple endocrine neoplasia, type 2, von hippel-lindau disease, hereditary paraganglioma syndrome, neurofibromatosis 1 (NF1). The first choice for the therapy of the tumor is surgical resection but before this some test are necessary. Whereas, there are so many organizations and key players are doing new innovations for the better treatment of pheochromocytoma and also sharing the relevant information about the cure which are helping to the patients of the pheochromocytoma.

Geographically, it is expected that the treatment market of the pheochromocytoma is spread across the Asia-Pacific region, Europe, and North America. Moreover, it is observed that in certain cases the tumor can be completely removed through surgery if the cure will be taken on time for the pheochromocytoma. With the inauguration of new healthcare centers and innovations in the technology for the cure and help to the victims in living peaceful life, the future of this clinical trials is expected to be bright in the coming years.

To know more, click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Growing Potential of the UK Pet Insurance Market Outlook: Ken Research

Pet insurance is a niche insurance which is systematize to cover the medical expenses if any insured pet become ill or is injured in any accident. Pet insurance cover some policies with the type of animals. Pets are legally regarded to be the property of their owners. In the insurance company the most products cater for the cats and dogs, although there are more policies available for rabbit, horses and others. Mainly, the policies have been split into three categories lifetime policies, mid-level policies, basic-level policies. Moreover, many of the persons believe that pet insurance is a variation of human health insurance whereas the pet insurance is actually a form of property insurance. With the time the pet insurance compensate the owner after the pet has received care and the owner submits a claim to the insurance company. The policy of the pet insurance is depending on the strategies of the company hence, the policies differ with numerous companies which are currently working in the pet insurance industry.
Add caption
In the earlier time most pet insurance plans did not for preventative care or elective procedures but in the recent trends many companies such as The United Kingdom, Canada and the United States are offering comprehensive coverage such as routine –care coverage. Whereas, many companies are providing limit coverage for the health care of pet which refers pre – existing condition in order to eliminate fraudulent consumers. Some insurers provide options which are not related to pet health, including costs associated with retrieving lost animals. Some British polices for pets include third-party liability insurance such as when a pet such as dog met with a car accident that damages a vehicle, the insurer will have to compensate the damage for which the owner is responsible under the Animals Act 1971. In addition some policies also involve travel cancellation coverage such as if owners must remain with pets who need urgent treatment or are dying.
According to the report analysis, ‘UK PET INSURANCE: MARKET DYNAMICS AND OPPORTUNITIES 2018’  suggests that the UK pet insurance experienced another year of growth in 2017, with total market gross written premiums of GBP1, 190m – an increase of 13.8% compared to 2016. The number of policies also grew considerably by 10.9% to reach 3.76 million. Yet there is still considerable potential for further growth as the majority of pets in the UK remain uninsured. Medical inflation remains one of the main driving forces behind the increase in GWP, with insures passing on the cost of policy holders. The sustainability of premium increases endures as this market’s greatest challenge and treat. Moreover, the dog insurance market represents the largest percentage of the total pet market. With the UK population of cats and dogs estimated to be similar in size, product uptake appears to be lowest in the cat market, while premiums are higher in the dog market. Therefore, the increasing cost of pet healthcare is likely to drive growth within the market. Moreover, the technological development in UK is also play a significant role in this market such wearable devices offer a major opportunity. Hence, the market of UK pet insurance is expected to grow in coming years.
To know more, click on the link below:
Related Reports:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Increase In The Demand Of Baby Food Sector In Portugal Market Outlook: Ken Research

Most importantly baby food sector is expected to grow significantly and the recent scenario also represents the significant growth in the plans of the market. According to the report analysis, ‘THE BABY FOOD SECTOR IN PORTUGAL, 2018’ suggests that the supply of baby food is now in the hands of two major manufactures such as Nestle and DANONE which hold a combined 80.0% of market share. Nestle is a Swiss company which is having nearly half of the entire value share due to its operations in various branches of baby food. Moreover, DANONE and MILUPA are also prominent players of this market in the Portugal. DANONE is majorly famous for milk products and cereals whereas the MILUPA is a constant player that has differentiated the food products of baby in bottled milk formula such as APTAMIL which is widely used product and highly renowned. Moreover, in the Portugal canned and packaged baby food such as fruit and baby rice is observed advantageous supplement to the homemade baby food.
The hectic new lifestyle has created a demand for prepared food which is available in the baby food market of Portugal. Moreover, Italy has the lowest birth rate in Europe followed by Portugal but the crises of the economic landscape of the country cannot be contradicted. In the past years, recession in the economy of Portugal resulted postpone in the decision to have babies but in the recent trend the country has marked reduction in population by a least margin. In Europe the birthrates had been reducing for a very long period even before the 2000s however, condition was changed somewhat when the European governments greeted immigration and benefited the young couples with cash for starting families. The situation seems to be degenerate one more time and the Portugal is between from those countries which bearing the brunt as the consumption of baby food product turns out to be lower when analysis to that at the starting of the decade.
In the economy of Portugal the number of working mothers is growing significantly which choose the milk formula actively for infants as they cannot be feed up by the solid food in the early stages and this product is witnessing the growth in the market of baby food product. In addition, the parents are becoming more concern and aware about the health of the infant which also is fuel to this industry for market growth as many key players are working very effectively in this industry for producing the baby food product. Milks formula accounts for the largest share in the industry of baby food product. Moreover, in the recent time constraints have reduced the usage of homemade baby food in both developed and developing nations.
With the increase in the concern various health organizations were opened which provide the information related to the baby food product to the parents which results in the significant increase in the demand for baby food product. Whereas, with the increase in the demand the baby food product is split in the market such as the baby food is available either in soft or liquid paste. Therefore, the industry of baby food sector market in Portugal will grow in the coming in a significant manner.
To know more, click on the link below:
Related Reports:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Increase in the Demand of Global Clinical Trials for Pheumonia Market Outlook: Ken Research

Pneumonia is an infection which majorly occurs in lungs. Anyone can get this lung infection but those who are not having strong immune system including infants younger than age 2 and people over age 65 have the highest odds can might be suffer with this infection majorly. Sometime the existence of pneumonia is not known by the patients whereas doctors call it “walking pneumonia” because if it is caused by a virus or bacteria then it can be spread to others as well. It can also be caused by the lifestyle habits such as drinking of alcohol and smoking cigarettes. Moreover, flu virus, RSV virus, cold virus, bacteria, fungi also cause pneumonia. Some causes are associated with classis, but non-specific, clinical characteristics. Whereas, pneumonia was historically divided into “typical” and “atypical”. Productive cough, shortness of breath, an increased rate of breathing and others are the signs and symptoms of pneumonia infection.

According to the report analysis, ‘Pneumonia Global Clinical Trials Review, H1, 2018’ suggests that some of the major companies and healthcare organizations which are functioning effectively for the superior treatment of pneumonia including Pfizer Inc, GlaxoSmithKline Plc, Merck & Co Inc, AstraZeneca Plc, Sanofi Allergan Plc, Novartis AG, Johnson & Johnson, Bayer AG, Wockhardt Ltd, Hoffmann-La Roche Ltd., Eli Lilly and Company, North Central Cancer Group, Columbia University, North Central Cancer Group, Copharos Inc., National Cancer Center, Eisai Inc., Dana-Farbar Cancer Institute, Cancer Research UK, University of Pennsylvania, Mayo Clinic, Ohio State University, Case Comprehensive Cancer Center and others. Therefore, for reducing the problem of pneumonia infection more and more organization and companies are working together with more upgrading technology, improved strategies and policies and new investments plans which have resulted in the market growth of the clinical trials.

Geographically, the global pneumonia treatment market is split into the Asia-Pacific region, Europe, North America, Middle East and Africa, Central and South America which showcase prominent in the rehabilitation of the pneumonia disease. With the increase in the strengthen of pneumonia infection most of the government healthcare institutions are working more actively with upgradation in the technologies and improved policies which resulted in the growth of the market and make the market players more active about the rehabilitation of the disease. Moreover, for the better treatment of pneumonia various test have to be taken before the diagnosis such as physical test, x-rays and others. In addition, for getting rid from this infection various prevention need to be taken such as make sure children get vaccinated, do not smoke, keep immune system strong, practice good hygiene and others.

With various research and developments in the treatment of pneumonia anyone can be live healthy life. Whereas, the bacterial pneumonia is treated by the antibiotics and viral pneumonia will take time for the recovering. With any kind of pneumonia the patient need lots of rest. Moreover, new innovations were done for the better cure and help to the patients for living risk free life, the future of this clinical trials is expected to bright in the coming years.

To know more, click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Rising Demand in the Global Clinical Trials for Phlebitis Market Outlook: Ken Research

Inflammation of vein means phlebitis. Phlebitis often occurs in conjunction with thrombosis and is then called thrombophlebitis or superficial thrombophlebitis. Thrombophlebitis is due to one or more blood clots in a vein that inflammation. Thrombophlebitis usually occurs in leg veins, but it may also affect the veins in the arms. Phlebitis can occur in both the surface (superficial) or deep veins. Whereas, superficial phlebitis affects veins on the skin surface and phlebitis in the deep veins is referred to as deep vein thrombophlebitis which affect the veins located deeper. The condition of superficial phlebitis is rarely serious and can be treated with local treatment of the inflammation with anti-inflammatory medications and warm compress. Localized redness and swelling, vein become hard and cord like are the major symptoms of phlebitis. Whereas, the symptoms may be become worsen when the leg is lowered, especially during getting out of bed in the morning and the surrounding area may sore and tender along the vein.

According to the report analysis, ‘Phlebitis Global Clinical Trials Review, H1, 2018’ some of the major companies and healthcare organizations are currently functioning for the better treatment of phlebitis such as Novartis AG, Troikaa Pharmaceuticals Ltd, Pfizer Inc, Mucos Pharma, GmbH & Co KG, Johnson & Johnson, GlaxoSmithKline Plc, DKSH Holding Ltd., Cumberland Pharmaceuticals Inc., Bayer AG, Baptist health South Plorida Inc., Bristol-Myers Squibb Company, Abbott Laboratries, Celegene orporation, Eli Lilly and Company, Daiichi Sankyo Company, GE Healthcare, Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, North Central Cancer Group, Dana-Farber Cancer Institute, European Organization for Research and Treatment of Cancer and others.  In addition, with more research & development in the medicines and upgradation in the technology in the treatment of phlebitis disease many organizations and key players are performing their job very effectively for helping more innovatively to the patients which are suffering from this disease.

By local trauma to a veins the disease of phlebitis is caused whereas the superficial phlebitis is most often caused by and intravenous catheter (IV) placed in a vein which cause irritation. Blood clotting abnormalities, inactivity, traumas are the causes of deep vein thrombosis. Besides the causes there are some risk factors of deep vein thrombosis which includes smoking cigarettes, especially when combines with hormone replacement therapy, certain medical conditions such as cancer, injury to the arms or legs and others. The medical care of phlebitis is very much reasonable if there is swelling or pain. On the other hand, major risk factors for deep vein thrombophlebitis includes recent surgery, bed rest and others whereas the symptoms of deep vein thrombophlebitis include lumps in a leg, severe pain, swelling in an arm or leg, high fever with any symptoms in leg or an arm requires immediate medical care. Geographically, the Asia-Pacific, Europe, America, East and Africa showcase the prevalence in the better treatment of the phlebitis treatment.

Additionally, for the better treatment many organizations are working with other players more actively. Before any clinical treatment various tests are to be done such as ultrasound which can detect the clots and others. Moreover, for solving the problem of phlebitis more and more companies and organizations are working with more improved technologies and new investment plans which resulted in the significant growth of the market in the coming years and the healthcare organizations have become more auspicious in the better treatment for the phlebitis.

To know more, click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Rising Demand of Oil and Gas Pipeline Globally Market Outlook: Ken Research

Transportation of oil and natural gas can be done through pipelines. Pipeline transport is a long distance transportation of oil and gas through a systematize attachment of pipes. Moreover, a pipeline is market area for consumption of oil and gas. Not only gas and oil to be transported through pipelines, chemically substances can also be sent through the pipelines. In addition, through pipelines water for drinking or irrigation to be transported over long distances where water is need such as over hills or where the facility of canal is very poor due to pollution or environmental impact. Usually buried pipelines are used to transport oil which is made up of steel or plastic whereas natural gas pipelines are constructed of carbon steel. Moreover, significant increase in the demand of oil and natural gas as a fuel has driven the tremendous growth in the construction of pipeline which further resulted in the market growth of oil and gas pipeline globally.
In the Asia-Pacific region, demand for natural gas is increasing so they largely construct pipelines for the domestic transportation of natural gas in the country.  Moreover, oil and natural gas is of low density which result increase in the transportation of oil and gas through pipeline as it is not easy to store or transport through vehicle. It is also expected that in North America major pipelines are to be constructed or start operating for supplying gas and oil in the other regions. Establishment pipeline for the transportation of oil and gas in the US displaces transportation of the natural gas through ships. Not only has this pipelines are much economical from other ways of transportation which resulted in the significant growth in the market of oil and gas pipeline. 
According to the report analysis, ‘GLOBAL OIL AND GAS PIPELINES INDUSTRY OUTLOOK TO 2022 – CAPACITY AND CAPITAL EXPENDITURE FORECASTS WITH DETAILS OF ALL OPERATING AND PLANNED PIPELINES’ suggests that recent developments and increase in latest awarded contracts at regional level resulted in the significant growth in the oil and gas pipeline market. However, the market structure remains moderately concentrated for the construction of oil and gas pipeline as it depend upon the huge capital investment, whereas technological knowledge makes it a big challenge for the new entrants in the market. The natural gas has been known as a key substitute of crude oil to generate power which makes it outstanding resource in the Asia-Pacific region followed by other regions such as Europe.
The demand for natural gas is expected to grow globally which leads to significant increase in the demand for natural gas pipeline. With the increase in the demand of oil and gas pipeline the key players are benefited from the development of strategic accordingly with the center companies. Whereas booming unconventional oil and gas production is in turn driving growth of the pipeline network in the US. Moreover, Russia is also expanding the oil and gas pipeline for exports, whereas the oil and gas can be transported from production centers to demand centers which results the market of oil and gas pipeline of both such as of importer and exporter. Therefore, the market of oil and gas pipeline market will grow in the coming years positively.
To know more, click on the link below:
Related Reports:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249